Earnings Scheduled For March 13, 2024 - Aadi Bioscience (NASDAQ:AADI), ProFrac Holding (NASDAQ:ACDC)
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.